Terms: = Lymphoma AND NOTCH2, Q04721, 4853, ENSG00000134250, AGS2, hN2
133 results:
1. Pathogenic Variants Associated with Epigenetic Control and the NOTCH Pathway Are Frequent in Classic Hodgkin lymphoma.
Santisteban-Espejo A; Bernal-Florindo I; Montero-Pavon P; Perez-Requena J; Atienza-Cuevas L; Fernandez-Valle MDC; Villalba-Fernandez A; Garcia-Rojo M
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473705
[TBL] [Abstract] [Full Text] [Related]
2. Relapsed/Refractory Peripheral T-Cell lymphoma-Associated Hemophagocytic Lymphohistiocytosis With UNC13D and CD27 Germline Mutations.
Yang T; Chen R; Zhang M; Jing R; Geng J; Wei G; Luo Y; Xiao P; Hong R; Feng J; Fu S; Zhao H; Cui J; Huang S; Huang H; Hu Y
Cell Transplant; 2024; 33():9636897231221887. PubMed ID: 38183241
[TBL] [Abstract] [Full Text] [Related]
3. Primary central nervous system marginal zone lymphoma.
Flospergher E; Marino F; Calimeri T; Cangi MG; Ferreri AJM; Ponzoni M; Bongiovanni L
Br J Haematol; 2024 Jan; 204(1):31-44. PubMed ID: 38054330
[TBL] [Abstract] [Full Text] [Related]
4. NOTCH Signaling in Mantle Cell lymphoma: Biological and Clinical Implications.
Deshotels L; Safa FM; Saba NS
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373427
[TBL] [Abstract] [Full Text] [Related]
5. Marginal zone lymphomas.
Zucca E; Rossi D; Bertoni F
Hematol Oncol; 2023 Jun; 41 Suppl 1():88-91. PubMed ID: 37294969
[TBL] [Abstract] [Full Text] [Related]
6. Mechanism of action of chlormethine gel in mycosis fungoides.
Guenova E; Ortiz-Romero PL; Poligone B; Querfeld C
J Eur Acad Dermatol Venereol; 2023 Sep; 37(9):1739-1748. PubMed ID: 37262305
[TBL] [Abstract] [Full Text] [Related]
7. DLBCL-associated notch2 mutations escape ubiquitin-dependent degradation and promote chemoresistance.
Zhou N; Choi J; Grothusen G; Kim BJ; Ren D; Cao Z; Liu Y; Li Q; Inamdar A; Beer T; Tang HY; Perkey E; Maillard I; Bonasio R; Shi J; Ruella M; Wan L; Busino L
Blood; 2023 Sep; 142(11):973-988. PubMed ID: 37235754
[TBL] [Abstract] [Full Text] [Related]
8. Deciphering the spectrum of cutaneous lymphomas expressing TFH markers.
Donzel M; Trecourt A; Balme B; Harou O; Mauduit C; Bachy E; Guesquières H; Fontaine J; Ortonne N; Perier-Muzet M; Dalle S; Traverse-Glehen A
Sci Rep; 2023 Apr; 13(1):6500. PubMed ID: 37081015
[TBL] [Abstract] [Full Text] [Related]
9. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
Shen R; Fu D; Dong L; Zhang MC; Shi Q; Shi ZY; Cheng S; Wang L; Xu PP; Zhao WL
Signal Transduct Target Ther; 2023 Apr; 8(1):145. PubMed ID: 37032379
[TBL] [Abstract] [Full Text] [Related]
10. Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma.
Tatarczuch M; Waltham M; Shortt J; Polekhina G; Hawkes EA; Ho SJ; Trotman J; Brasacchio D; Co M; Li J; Ramakrishnan V; Dunne K; Opat SS; Gregory GP
Blood Adv; 2023 Jul; 7(14):3531-3539. PubMed ID: 36947202
[TBL] [Abstract] [Full Text] [Related]
11. Waldenström Macroglobulinemia and Non-IgM-Type Lymphoplasmacytic lymphoma Are Genetically Similar.
Awata-Shiraiwa M; Yokohama A; Kanai Y; Gotoh N; Kasamatsu T; Handa H; Saitoh T; Murakami H; Hirato J; Ikota H; Tsukamoto N
Acta Haematol; 2023; 146(5):384-390. PubMed ID: 36917966
[TBL] [Abstract] [Full Text] [Related]
12. Combined Reverse-Transcriptase Multiplex Ligation-Dependent Probe Amplification and Next-Generation Sequencing Analyses to Assign Unclassified BCL2
Sesboue C; Galtier J; Jeanneau M; Chauvel A; Laharanne E; Amintas S; Merlio JP; Bouabdallah K; Gros FX; de Leval L; Gros A; Parrens M
Mod Pathol; 2023 Feb; 36(2):100043. PubMed ID: 36853790
[TBL] [Abstract] [Full Text] [Related]
13. Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma.
Yuan X; Li X; Huang Y; Jin X; Liu H; Zhao A; Zhang W; Qian W; Liang Y
Front Immunol; 2022; 13():1015081. PubMed ID: 36505470
[TBL] [Abstract] [Full Text] [Related]
14. Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape.
Mangolini M; Maiques-Diaz A; Charalampopoulou S; Gerhard-Hartmann E; Bloehdorn J; Moore A; Giachetti G; Lu J; Roamio Franklin VN; Chilamakuri CSR; Moutsopoulos I; Rosenwald A; Stilgenbauer S; Zenz T; Mohorianu I; D'Santos C; Deaglio S; Hodson DJ; Martin-Subero JI; Ringshausen I
Nat Commun; 2022 Oct; 13(1):6220. PubMed ID: 36266281
[TBL] [Abstract] [Full Text] [Related]
15. EZH2 inhibitor DZNep blocks cell proliferation of GCB-DLBCL cells by upregulating p16.
Wang P; Xu L; Fan Y; Li B; Chen P; Zhang X; Sun Y; Fu J
Leuk Lymphoma; 2022 Dec; 63(14):3370-3377. PubMed ID: 36239491
[TBL] [Abstract] [Full Text] [Related]
16. Intravascular Large B-Cell lymphoma Genomic Profile Is Characterized by Alterations in Genes Regulating NF-κB and Immune Checkpoints.
Gonzalez-Farre B; Ramis-Zaldivar JE; Castrejón de Anta N; Rivas-Delgado A; Nadeu F; Salmeron-Villalobos J; Enjuanes A; Karube K; Balagué O; Cobo F; Kelleher N; Victoria I; Veloza L; Teixido C; Giné E; Lopez-Guerra M; Quintanilla-Martinez L; Lopez-Guillermo A; Salaverria I; Campo E
Am J Surg Pathol; 2023 Feb; 47(2):202-211. PubMed ID: 36221796
[TBL] [Abstract] [Full Text] [Related]
17. Histiocytic Sarcoma With CCND1 Gene Rearrangement Clonally Related and Transdifferentiated From Mantle Cell lymphoma.
Kumar J; Al-Kawaaz M; Martin BA; Hegazi MM; Tan B; Gratzinger D
Am J Clin Pathol; 2022 Oct; 158(4):449-455. PubMed ID: 35964234
[TBL] [Abstract] [Full Text] [Related]
18. Pediatric-Type Indolent B-Cell lymphomas With Overlapping Clinical, Pathologic, and Genetic Features.
Lim S; Lim KY; Koh J; Bae JM; Yun H; Lee C; Kim YA; Paik JH; Jeon YK
Am J Surg Pathol; 2022 Oct; 46(10):1397-1406. PubMed ID: 35834399
[TBL] [Abstract] [Full Text] [Related]
19. Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation.
Righi S; Novero D; Godio L; Bertuzzi C; Bacci F; Agostinelli C; Sagramoso C; Rossi M; Piccioli M; Gazzola A; Mannu C; Roncador G; Sabattini E
Hum Pathol; 2022 Jun; 124():67-75. PubMed ID: 35339566
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma.
Kim E; Jiang Y; Xu T; Bazeos A; Knapp A; Bolen CR; Humphrey K; Nielsen TG; Penuel E; Paulson JN
BMC Cancer; 2022 Mar; 22(1):231. PubMed ID: 35236331
[TBL] [Abstract] [Full Text] [Related]
[Next]
